Flagship’s ProFound partners with Gates Foundation in $35M preeclampsia target discovery pact

Flagship Pioneering’s ProFound Therapeutics is keeping its string of high-profile partnerships going, forging a new pact with the Gates Foundation worth up to $35 million to find new drug targets for a dangerous pregnancy complication.